Lake Street resumed coverage on Streamline Health with a new price target
$STRM
EDP Services
Technology
Lake Street resumed coverage of Streamline Health with a rating of Buy and set a new price target of $3.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/21/2022 | $3.00 | Buy | Lake Street |
10-Q - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
8-K - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
NT 10-Q - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
ATLANTA, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of RevID with a 120-bed, Oracle Health-EHR based health system with facilities in Kentucky. Closed in partnership with Oracle Health, this agreement marks Streamline Health's fourth CommunityWorks Oracle EHR client—an important milestone underscoring the growing adoption of its pre-bill technology solution. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. RevID's a
ATLANTA, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of eValuator with Deaconess Health System, a 1,200 bed Indiana-based health system. Deaconess selected Streamline Health's eValuator solution to optimize its pre-bill coding accuracy and financial outcomes. "We were seeking automation to assist with improving coding and billing workflows as well as accuracy within the mid-revenue cycle. eValuator's unique capabilities stood apart and best fit our organizational priorities" stated Rebecca Conen, V
ATLANTA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of RevID with a 400-bed, Oracle Health-EHR based health system with facilities in Western Texas. The deal was closed in partnership with Oracle Health. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. RevID's automated charge reconciliation enables hospitals to capture 100% of earned revenue by eliminating charge capture gaps and accelerates cash flow by ensuring t
Lake Street resumed coverage of Streamline Health with a rating of Buy and set a new price target of $3.00
Net loss of ($2.5 million) during the third quarter of fiscal 2024 compared to a net loss of ($11.9 million) during the third quarter of fiscal 2023Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectationCompany accelerated expectation for achievement of SaaS ARR adjusted EBITDA breakeven run rate to the first half of fiscal 2025 ATLANTA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the third quarter of
ATLANTA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended October 31, 2024 on Monday December 16, 2024 after the close of the financial markets. The Company will conduct a conference call on Tuesday, December 17, 2024, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join by phon
Net loss of ($2.8 million) during the second quarter of fiscal 2024 compared to a net loss of ($2.5 million) during the second quarter of fiscal 2023Adjusted EBITDA improved to a loss of ($0.3 million) for the second quarter of fiscal 2024 compared to a loss of ($0.9 million) for the second quarter of fiscal 2023Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectationCompany updated expectation for achievement of SaaS ARR adjusted EBITDA breakeven run rate to the second half of fiscal 2025 ATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions
Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million of installed SaaS ARR during the second half of fiscal 2024 Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew EtheridgeClosed private placement of unsecured subordinated notes and warrants and private placement of common stock resulting in aggregate gross proceeds of approximately $4.5 millionModified existing senior loan covenants Atlanta, GA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM) ("Streamline" or "the Company"), a leading provider of solutions that enable healthc
SC 13G - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13D/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13G/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)